Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 16(4), 1994, pp. 303-305
Citations number
9
Categorie Soggetti
Immunology,Oncology,"Medicine, Research & Experimental
Ten patients with metastatic breast cancer were treated with a combina
tion of recombinant alpha-interferon and recombinant interleukin-2. Th
e toxicity of treatment was considerable, including one death on thera
py. No objective responses were seen.